Loading...

World-Class Retina Care. Community-Based Caring.

10 New Clinical Trials Available at Texas Retina

Posted On February 19, 2025 / By / Posted in Blog

10 New Clinical Trials Available at Texas Retina

In the last two decades, medical researchers have made significant advances in the diagnosis and treatment of retina conditions, discovering new sight-saving treatments for diseases that once robbed patients of their vision.

read more
Posted On February 17, 2025 / By / Posted in Blog

Getting to Know Rene Y. Choi, MD, PhD

Texas Retina was fortunate to have board-certified ophthalmologist and retina specialist Rene Choi, MD, PhD, join our team in September 2020, and he currently cares for patients in our Denton and Frisco

read more
Posted On February 14, 2025 / By / Posted in Blog

We Love Our Patients!

At Texas Retina, our patients are at the HEART of everything we do. Thank you for placing your trust in us. Happy Valentine’s Day!

read more
Posted On February 12, 2025 / By / Posted in Blog

Dr. Abbey Discusses Injectable Retina Treatments on AAO Podcast

On a recent episode of the American Academy of Ophthalmology’s “Experts InSight” podcast, Texas Retina’s Ashkan Abbey, MD, joined Ehsan Rahimy, MD, and host Jay Shridhar, MD, to discuss recent developments in

read more
Posted On February 11, 2025 / By / Posted in Blog

Dr. Christopher Fuller Won Best in Show at Telluride Retina Film Festival

This past weekend, Texas Retina’s Christopher G. Fuller, MD, presented a video at the Telluride Retina Film Festival, a three-day conference that brings together retina specialists from throughout the Western hemisphere to

read more
Posted On February 10, 2025 / By / Posted in Blog

Understanding and Reducing Your Risk for AMD

February is Age-Related Macular Degeneration Awareness Month. A serious degenerative eye disease that can cause irreversible vision loss or blindness if left untreated, AMD is the most common reason patients are referred

read more
Posted On February 4, 2025 / By / Posted in Blog

Texas Retina Research Team Publishes New Study on Wet AMD Treatment

Texas Retina’s Ashkan Abbey, MD; Paige Abril, BS; and Rachel McCullough, BS, recently published a retrospective study in the peer-reviewed journal Ophthalmic Surgery, Lasers and Imaging Retina titled, “Outcomes of Intravitreal Aflibercept

read more
Posted On February 3, 2025 / By / Posted in Blog

Honoring the Life and Legacy of Texas Retina Co-founder Albert Vaiser, MD

It is with great sadness that Texas Retina announces the passing of one of its three founders, Albert Vaiser MD, on Saturday, February 1, 2025, after a brief illness. Dr. Vaiser had celebrated

read more
Posted On January 29, 2025 / By / Posted in Blog

Dr. Wang Discussed CLARITY Clinical Trial Enrollment at Presentation in Miami

Robert Wang, MD, Texas Retina’s Director of Clinical Research for Plano, recently spoke about the CLARITY clinical trial at a meeting of retina specialists held in Miami, Florida. A global, multi-center Phase

read more
Posted On January 27, 2025 / By / Posted in Blog

Dr. Abbey Presented First-Year Results of DAVIO 2 Clinical Trial at Hawaiian Eye and Retina 2025

Texas Retina’s Ashkan M. Abbey, MD, presented “DAVIO 2: Year 1 Results from a Phase 2, Multicenter, Non-Inferiority Trial of EYP-1901 (Vorolanib Intravitreal Insert) versus Aflibercept for Previously-Treated Wet Age-Related Macular Degeneration”

read more